| Mrs Margaret Ann Wright, CNM | |
|
1135 North Way E, Darien, GA 31305-2690 | |
| (912) 437-2442 | |
| (912) 437-7774 |
| Full Name | Mrs Margaret Ann Wright |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 18 Years |
| Location | 1135 North Way E, Darien, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801010020 | NPI | - | NPPES |
| 003107497B | Medicaid | GA | |
| 003107497ABC | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | ANT 9207260 (Florida) | Secondary |
| 367A00000X | Advanced Practice Midwife | RN165440 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southeast Georgia Health System- Brunswick Campus | Brunswick, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Darien Primary Care Inc | 8022283175 | 2 |
News Archive
Intercept Pharmaceuticals, Inc., today announced positive results from a 59 patient, placebo controlled, double-blind Phase II clinical trial of obeticholic acid given as monotherapy to patients with primary biliary cirrhosis.
Huda Zoghbi, of Baylor College of Medicine and the Howard Hughes Medical Institute and Juan Young, also of Baylor and colleagues report in the online Early Edition of the Proceedings of the National Academy of Science, posted the week of October 17, 2005, that the Rett Syndrome gene, MECP2, regulates RNA splicing.
Researchers at the University of Luxembourg have identified potential new ways to test for the first signs of one of the most deadly types of cancer: colorectal cancer. They have found new "biomarkers": molecules whose increased presence or absence in tissue suggests the development of tumorous cells. These indicators could help detect colorectal cancer at an early stage, predict its severity or even offer new treatments.
Fatigue is associated with disease severity in patients with chronic obstructive pulmonary disease, researchers confirm.
Guidant Corporation, Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart.
› Verified 9 days ago
| Entity Name | Darien Primary Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467738559 PECOS PAC ID: 8022283175 Enrollment ID: O20111219000627 |
News Archive
Intercept Pharmaceuticals, Inc., today announced positive results from a 59 patient, placebo controlled, double-blind Phase II clinical trial of obeticholic acid given as monotherapy to patients with primary biliary cirrhosis.
Huda Zoghbi, of Baylor College of Medicine and the Howard Hughes Medical Institute and Juan Young, also of Baylor and colleagues report in the online Early Edition of the Proceedings of the National Academy of Science, posted the week of October 17, 2005, that the Rett Syndrome gene, MECP2, regulates RNA splicing.
Researchers at the University of Luxembourg have identified potential new ways to test for the first signs of one of the most deadly types of cancer: colorectal cancer. They have found new "biomarkers": molecules whose increased presence or absence in tissue suggests the development of tumorous cells. These indicators could help detect colorectal cancer at an early stage, predict its severity or even offer new treatments.
Fatigue is associated with disease severity in patients with chronic obstructive pulmonary disease, researchers confirm.
Guidant Corporation, Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Margaret Ann Wright, CNM Po Box 2690, Darien, GA 31305-2690 Ph: (912) 437-2442 | Mrs Margaret Ann Wright, CNM 1135 North Way E, Darien, GA 31305-2690 Ph: (912) 437-2442 |
News Archive
Intercept Pharmaceuticals, Inc., today announced positive results from a 59 patient, placebo controlled, double-blind Phase II clinical trial of obeticholic acid given as monotherapy to patients with primary biliary cirrhosis.
Huda Zoghbi, of Baylor College of Medicine and the Howard Hughes Medical Institute and Juan Young, also of Baylor and colleagues report in the online Early Edition of the Proceedings of the National Academy of Science, posted the week of October 17, 2005, that the Rett Syndrome gene, MECP2, regulates RNA splicing.
Researchers at the University of Luxembourg have identified potential new ways to test for the first signs of one of the most deadly types of cancer: colorectal cancer. They have found new "biomarkers": molecules whose increased presence or absence in tissue suggests the development of tumorous cells. These indicators could help detect colorectal cancer at an early stage, predict its severity or even offer new treatments.
Fatigue is associated with disease severity in patients with chronic obstructive pulmonary disease, researchers confirm.
Guidant Corporation, Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart.
› Verified 9 days ago